¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cognitive death"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cognitive remediation
    ÀÎÁö±³Á¤
  • cognitive restructuring
    ÀÎÁöÀ籸Ãà
  • cognitive scale
    Àνĵî±Þ
  • cognitive skill
    ÀÎÁö±â¼ú
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ
  • cognitive structure
    ÀÎÁö±¸Á¶
  • cognitive therapy
    ÀÎÁö¿ä¹ý
  • accidental death
    »ç°í»ç, ÀçÇØ»ç
  • apparent death
    °¡»ç, °Ñº¸±â»ç¸Á
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    Á¶Á¤»ç¸Á·ü
  • age-specific death rate
    ¿¬·Éº°»ç¸Á·ü
  • birth-death ratio
    Ãâ»ý»ç¸Áºñ
  • brain death
    ³ú»ç
  • brain death syndrome
    ³ú»çÁõÈıº
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sudden infant death syndrome
    ¿µ¾Æ±Þ»çÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cognitive restructuring
    ÀÎÁöÀ籸Ãà
  • cognitive scale
    ÀνÄÀÚ
  • cognitive skill
    ÀÎÁö±â¼ú
  • cognitive structure
    ÀÎÁö±¸Á¶
  • cognitive therapy
    ÀÎÁö¿ä¹ý
  • cognitive evoked potential
    ÀνÄÀ¯¹ßÀüÀ§
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ
  • cognitive-acting drug
    ÀÎÁö±â´ÉȰ¼ºÁ¦
  • cognitive-perceptual skill training
    ÀÎÁöÁö°¢±â¼úÈÆ·Ã
  • social-cognitive learning theory
    »çȸÀÎÁöÇнÀÀÌ·Ð
  • accidental death
    »ç°í»ç, ÀçÇØ»ç
  • actual death rate
    ½ÇÁ¦»ç¸Á·ü
  • adjusted death rate
    (¢¡standardized death rate) Ç¥ÁØÈ­»ç¸Á·ü
  • age-specific death rate
    ¿¬·Éº°Æ¯¼ö»ç¸Á·ü
  • apparent death
    °¡»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • postoperative death
    ¼úÈÄ»ç(¡­»ç).
  • postoperative death
    ¼úÈÄ»ç(âúý­ÞÝ)
  • prenatal death
    Ãâ»ýÀü»ç¸Á
  • programmd cell death
    ¼¼Æ÷¿¹Á¤»ç
  • puerperal death rate
    »ê¿å»ç¸Á·ü (ÊÙË×ËÎËô).
  • puerperal death rate
    »êÈÄ»ç¸Á·ü,»ê¿å»ç¸Á·ü (¡­ÞÝØÌëÒ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • cognitive rehearsal
    ÀÎÁö¿¹Ç࿬½À(ìãò±çãú¼æÑã§)
  • cognitive remediation
    ÀÎÁöÀçÁ¶Á¤(ìãò±î¢ðàïá)
  • cognitive restructuring
    ÀÎÁöÀû À籸Ãà(ìãò±îÜ î¢Ï°õé)
  • cognitive skill
    ÀÎÁö±â¼ú(ìãò±Ðüâú)
  • cognitive social learning
    ÀÎÁö»çȸÇнÀ(ìãò±ÞäüåùÊã§)
  • cognitive structure
    ÀÎÁö±¸Á¶(ìãò±Ï°ðã)
  • cognitive therapy
    ÀÎÁö¿ä¹ý(ìãò±èþÛö)
  • cognitive-acting drug(=enhancer)
    ÀÎÁö±â´ÉȰ¼ºÁ¦(ìãò±Ñ¦ÒöüÀàõð¥)
  • cognitive-behavioral therapy
    ÀÎÁö-Çൿ ¿ä¹ý(ìãò±ú¼ÔÑèþÛö)
  • cognitive-perceptual skill training
    ÀÎÁö-Áö°¢±â¼úÈÆ·Ã(ìãò±-ò±ÊÆÐüâúýºÖ¨)
  • organic amnesic syndrome, mild cognitive disorder
    ±âÁú¼º ±â¾ï»ó½ÇÁõÈıº(ÑÀåãßÃã÷ñøý¦ÏØ), °æµµÀÎÁöÀå¾Ö(ÌîÓøìãò±î¡äô)(º´)
  • social-cognitive learning theory
    »çȸÀÎÁöÇнÀÀÌ·Ð
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • accidental death
    »ç°í»ç(ÞÀͺÞÝ)
  • accidental death
    »ç°í»ç, ÀçÇØ»ç .
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
BCDS bulimia cognitive distortions scale
BCRS brief cognitive rating scale
CAMCOG Cambridge cognitive capacity scale
CAS calcarine sulcus; calcific aortic stenosis; Cancer Attitude Survey; carbohydrate-active steroid; car...
CASI cognitive abilities screening instrument
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CCSE Cognitive Capacity Screening Examination
CT Cognitive Therapy
CBT Cognitive behavioral treatment
GCI General Cognitive Index
IQCODE Informant Questionnaire on Cognitive Decline in The Elderly
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • brain death syndrome
    ³ú»ç ÁõÈıº
  • cell death
    ¼¼Æ÷»ç
    ¼¼Æ÷°¡ Á׾´Â °úÁ¤¿¡¼­ »ýü ÀÛ¿ëÀÌ ¼¼Æ÷ ¼öÁØ¿¡¼­ Áß´ÜµÈ ÁöÁ¡. ¼¼Æ÷»ç´Â Á¶Á÷À̳ª Àå±â¸¦ Àå±â ÀÌ½Ä °ø¿©Ã¼·Î »ç¿ëÇÏ´Â °Í¿¡ ¾Õ¼­ ÀϾ´Ù.
  • death certificate
    »ç¸ÁÁø´Ü¼­, ½Ãü°Ë¾È¼­
  • death ratio
    »ç¸Áºñ
    µ¿ÀǾî=
  • death wound
    Ä¡¸í»ó
    Á×À½ÀÇ ¿øÀÎÀÌ µÈ »óó.
  • electric death
    °¨Àü»ç
  • hebdomadal death rate
    »ýÈÄ ÀÏ ÁÖ°£ »ç¸Á·ü
  • immediate death
    Áï»ç, ¼ø°£»ç
  • manner of death
    »ç¸ÁÀÇ Á¾·ù
  • maternal death rate
    ¸ð¼º »ç¸Á·ü
  • molecular death
    ºÐÀÚ »ç
  • neocortical death
    ½Å ÇÇÁú»ç
  • neonatal death
    ½Å»ý¾Æ »ç¸Á
  • organ death
    Àå±â »ç¸Á
  • postoperative death
    ¼úÈÄ »ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
maternal death Death of a woman while pregnant or within 42 days after the termination of gestation, irrespective of the duration and site of pregnancy and the cause of death; two periods are recognised in the 42-day interval: period 1 includes day 1 to day 7; period 2 includes day 8 to day 42. Maternal death's are further classified as:
(05 Mar 2000)
maternal death rate The number of maternal deaths that occur as the direct result of the reproductive process per 100,000 live births.
See: rate.
See: maternal death.
(05 Mar 2000)
cause of death Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.
(12 Dec 1998)
cell death <cell biology> Cells die (nonaccidentally) either when they have completed a fixed number of division cycles (around 60, the Hayflick limit) or at some earlier stage when programmed to do so, as in digit separation in vertebrate limb morphogenesis.
Whether this is due to an accumulation of errors or a programmed limit is unclear, some transformed cells have undoubtedly escaped the limit.
See: apoptosis.
(26 Mar 1998)
cerebral death A clinical syndrome characterised by the permanent loss of cerebral and brain stem function, manifested by absence of responsiveness to external stimuli, absence of cephalic reflexes, and apnea. An isoelectric electroencephalogram for at least 30 minutes in the absence of hypothermia and poisoning by central nervous system depressants supports the diagnosis.
Synonym: brain death.
(05 Mar 2000)
perinatal death An inclusive term referring to both stillborn infants and neonatal death's.
(05 Mar 2000)
mitotic death <cell biology> Cells fatally damaged by ionising radiation may not die until the next mitosis, at which point the radiation damage to the DNA becomes evident, particularly when there is fragmentation of chromosomes.
(18 Nov 1997)
cot death <syndrome> May affect infants of any age, but some risk factors have been identified: term infants who have had a life-threatening period of apnoea (not breathing), premature infants of low birth weight, siblings of infants who have succumbed to sudden infant death syndrome and infants of substance abusing mothers.
Peak age is at 2.5 months and 4 months, but can range from 1 month to 1 year. High risk infants should have home monitoring done. It is recommended that the less than 4 month old infant should sleep on their back.
Synonym: cot death syndrome.
Incidence: 2 per 1,000 live births.
Acronym: SIDS
(27 Sep 1997)
crib death <syndrome> May affect infants of any age, but some risk factors have been identified: term infants who have had a life-threatening period of apnoea (not breathing), premature infants of low birth weight, siblings of infants who have succumbed to sudden infant death syndrome and infants of substance abusing mothers.
Peak age is at 2.5 months and 4 months, but can range from 1 month to 1 year. High risk infants should have home monitoring done. It is recommended that the less than 4 month old infant should sleep on their back.
Synonym: cot death syndrome.
Incidence: 2 per 1,000 live births.
Acronym: SIDS
(27 Sep 1997)
crude death rate <epidemiology> The number of deaths in a year divided by the population size.
(05 Dec 1998)
programmed cell death <cell biology, molecular biology> The concept that certain cells are determined to die at specific stages and specific sites during development, for example cells in the spaces between the developing digits of vertebrates, thus dividing them. Programmed cell death occurs by apopotosis.
(18 Nov 1997)
somatic death Death of the entire body, as distinguished from local death.
(05 Mar 2000)
neonatal death Death of a young, liveborn infant; classified as:
(05 Mar 2000)
sudden death An arrhythmogenic death in aortic stenosis, coronary disease, mesothelioma of the AV node, or single coronary artery.
(05 Mar 2000)
sudden infant death The abrupt and unexplained death of an apparently healthy infant under one year of age, remaining unexplained after a thorough case investigation, including performance of a complete autopsy, examination of the death scene, and review of the clinical history. (expert panel of the national institute of child health and human development in paediatric pathology, v.11, no.5, sept-oct 1991, p681)
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • death agony
    Á×À½ÀÇ °íÅë
  • death bell
    ÀÓÁ¾À» ¾Ë¸®´Â Á¾
  • death benefit
    (»ýº¸)»ç¸Á ±ÞºÎ±Ý
  • death cell
    »çÇü¼ö °¨¹æ(µ¶¹æ)
  • death certificate
    »ç¸Á Áø´Ü¼­(È®Àμ­)
  • death chair
    =ELECTRIC CHAIR
  • death chamber
    »çÇü½Ç;ÀÓÁ¾ÀÇ ¹æ
  • death cup
    °ú¸® ¹ö¼¸¼Ó(µ¶¹ö¼®)
  • death duty
    »ó¼Ó¼¼
  • death education
    Á×À½¿¡ °üÇÑ ±³À°(Á×À½ ¹× Á×À½¿¡ °üÇÑ ¹®Á¦µéÀ» ´Ù·ç´Â ±³À°)
  • death fire
    µµ±úºñºÒ(Á×À½ÀÇ Â¡Á¶)
  • death house
    »çÇü¼ö °¨¹æ
  • death instince
    Á×À½ÀÇ º»´É
  • death penalty
    »çÇü
  • death rate
    »ç¸Á·ü(mortality)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á